`
`(12) Patent Application Laid-Open Publication (A)
`
`(11) Publication Number: Japanese Patent Application Laid-Open Publication No. S64-29267
`
`(43) Publication Date: January 31, 1989
`(51) Int. Cl.4
`A61M 1/10
`
`Identification Code
`
`310
`
`JPO Reference Number
`
`7720-4C
`
`Request for Examination: Not filed
`
`Number of Invention: 1 (7 pages in total)
`
`(54) Title of Invention: Blood Pump
`
`(21) Application Number: Japanese Patent Application No. S62-185958
`
`(22) Filing Date: July 24, 1987
`
`(72) Inventor: Masaki SATO
`
`
`
`
`
`c/o Toyo Boseki Co., Ltd., Research Institute
`
`2-1-1 Katata, Otsu-shi, Shiga
`
`(72) Inventor: Kaoru SUGIHARA
`
`
`
`
`
`c/o Toyo Boseki Co., Ltd., Research Institute
`
`2-1-1 Katata, Otsu-shi, Shiga
`
`(72) Inventor: Osamu UEMOTO
`
`
`
`
`
`c/o Toyo Boseki Co., Ltd., Research Institute
`
`2-1-1 Katata, Otsu-shi, Shiga
`
`(71) Applicant: Toyo Boseki Co., Ltd.
`
`
`
`2-2-8 Dojimahama, Kita-ku, Osaka-shi, Osaka
`
`(74) Agent: Patent Attorney Shusaku YAMAMOTO
`
`1
`
`Nipro Ex. 1021
`
`000001
`
`
`
`Specification
`
`Title of invention
`
`Blood Pump
`
`Claims
`
`1. A blood pump that has a periphery of a diaphragm attached to a housing inner
`
`1.
`
`
`
`2.
`
`
`
`circumferential surface so as to divide a blood pump housing into a blood chamber and an air
`
`chamber, and circulates blood by pumping the diaphragm in pulses to cause the blood to once
`
`flow into the blood chamber and then flow out from the blood chamber,
`
`
`
`characterized in that the diaphragm is configured to have a thick peripheral portion
`
`and become gradually thinner towards a center portion.
`
`
`
`2. The blood pump of claim 1, characterized in that the film thickness of the
`
`peripheral portion is 0.2 to 2.0 mm, and the thickness of the center portion is 50 to 90% of the
`
`film thickness of the peripheral portion.
`
`3.
`
`Detailed Description of Invention
`
`(Industrial Applicability)
`
`[0001]
`
`
`
`The present invention relates to a diaphragm type blood pump used in the field of
`
`cardiac surgeries.
`
`(Background Art)
`
`[0002]
`
`
`
`In recent years, in the field of cardiac surgeries, a circulation assisting method that
`
`assists blood circulation during surgery and the like is being employed, and for example, an
`
`application of an intra-aortic balloon pumping method or a veno-arterial bypassing method on
`
`seriously ill heart disease patients may save the lives of such patients. However, for patients
`
`of heart failures who had gone into a serious condition by acute myocardial infarction or
`
`during open heart surgeries, problems are present in that the aforementioned intra-aortic
`
`balloon pumping method would not be effective due to the limit cast on its circulation
`
`2
`
`Nipro Ex. 1021
`
`000002
`
`
`
`assisting performance, and with the veno-arterial bypassing method, a large amount of
`
`anticoagulant must be used, which results in the presence of bleeding tendency, and
`
`occurrences of dysfunctions in other organs, or the like.
`
`[0003]
`
`
`
`As a substitute to the intra-aortic balloon pumping method and the veno-arterial
`
`bypassing method having such problems, a method of using an auxiliary artificial heart is
`
`recently being employed. A blood pump of the auxiliary artificial heart has the ability to
`
`take over partial or entire cardiac function of a patient who has gone into even a more serious
`
`condition of heart failure due to acute myocardial infarction or post-operational cardiogenic
`
`shock after the open heart surgery.
`
`[0004]
`
`
`
`A conventional blood pump for the auxiliary artificial heart has a diaphragm with a
`
`uniform thickness that divides an inside of an oval-spherical blood pump main body into two
`
`chambers, namely a blood chamber and an air chamber, where the blood chamber is provided
`
`therein with a blood inflow tube that allows the body blood to flow into the blood chamber
`
`and a blood outflow tube that allows the blood in the blood chamber to circulate in the body.
`
`A contraflow-preventing valve for preventing the blood in the blood chamber from adversely
`
`flowing into the blood inflow tube is installed between the blood inflow tube and the blood
`
`chamber being the housing, and a contraflow-preventing valve for preventing the blood in the
`
`blood outflow tube from adversely flowing into the blood chamber is installed between the
`
`blood outflow tube and the blood chamber.
`
`[0005]
`
`
`
`In such a conventional blood pump, the blood chamber first is inflated by sucking
`
`the diaphragm into the air chamber by discharging the air in the air chamber, and introducing
`
`the blood into the blood chamber via the blood inflow tube from within the body. Then, air
`
`is supplied to the air chamber to press the diaphragm into the blood chamber, whereby the
`
`blood chamber contracts to guide the blood in the blood chamber into the blood outflow tube.
`
`Accordingly, the air supply to the air chamber and the air discharge from the air chamber are
`
`repeated to pump the diaphragm in pulses to circulate the blood.
`
`3
`
`Nipro Ex. 1021
`
`000003
`
`
`
`(Problem Aimed to be Solved by Invention)
`
`[0006]
`
`
`
`In the conventional blood pump, the pulsing diaphragm has the unique film
`
`thickness. Due to this, a large negative pressure must be applied to the diaphragm for
`
`sucking a center portion of the diaphragm having the same thickness as its peripheral portion
`
`toward an air chamber side upon inflating the blood chamber to introduce blood flow into the
`
`blood chamber. With such an increased negative pressure, there is a risk that the blood
`
`might flow into the blood chamber in a surge, as a result of which blood emissary speed may
`
`become large, and hemolysis may occur. With a unique film thickness for the diaphragm,
`
`stress applied to the diaphragm accumulates locally upon pulsing the diaphragm, and the
`
`diaphragm is pumped in pulses in a state of being undulated. As a result of this, the portions
`
`where the stress in the diaphragm is accumulated has lower durability, and breakage may
`
`occur from that portion. Further, when the diaphragm is rippled, there is also a risk that a
`
`part of the blood stagnates in the blood chamber. With such stagnation of blood in the blood
`
`chamber, anti-coagulant performance would be lost, and there would be higher chances of
`
`blood clots.
`
`[0007]
`
`
`
`The present invention solves the above conventional problems, and aims to provide a
`
`blood pump with high durability, and that can pump its diaphragm in pulses by a relatively
`
`small driving force, as a result achieving less risk for undulation of the diaphragm upon being
`
`pulsed, thus maintaining its anti-coagulant performance, and that has no risk of hemolysis.
`
`(Means for Solving Problem)
`
`[0008]
`
`
`
`The present invention is a blood pump that has a periphery of a diaphragm attached
`
`to a housing inner circumferential surface so as to divide a blood pump housing into a blood
`
`chamber and an air chamber, and circulates blood by pumping the diaphragm in pulses to
`
`cause the blood to once flow into the blood chamber and then flow out from the blood
`
`chamber, characterized in that the diaphragm is configured to have a thick peripheral portion
`
`and become gradually thinner towards a center portion, by which the above aims are fulfilled.
`
`4
`
`Nipro Ex. 1021
`
`000004
`
`
`
`(Embodiment)
`
`[0009]
`
`
`
`
`
`Hereinbelow the present invention will be described with reference to drawings.
`
`As shown in FIG. 1 and FIG. 2, the blood pump of the present invention includes an
`
`oval-spherical housing 10, and a semispherical diaphragm 20 that divides the inside of a
`
`blood pump main body.
`
`[0010]
`
`
`
`The housing 10 is provided with a blood inflow tube part 11a (shown only in FIG. 1)
`
`and a blood outflow tube part 11b (shown only in FIG. 2) projecting therefrom, and includes
`
`a semispherical main body part 11 that configures an outer shell of a blood chamber 14, and a
`
`back plate part 12 that configures an outer shell of an air chamber 15 by being joined with a
`
`peripheral portion of the main body 11 in an airtight manner.
`
`
`
`At least an inner circumferential surface of the main body part 11 of the housing 10
`
`is formed of an anti-coagulant polymer material. Thus, an entirety of the main body 11 is
`
`formed for example of the anti-coagulant polymer material, or is formed of plastic and have
`
`its inner circumferential surface covered by the anti-coagulant polymer material.
`
`[0011]
`
`
`
`An outer peripheral edge of a diaphragm 20 formed in a semispherical shape by the
`
`anti-coagulant polymer material is attached airtight to the inner circumferential surface on the
`
`peripheral part of the main body part 11 of the housing 10, and it is formed integral with the
`
`anti-coagulant polymer material of the inner circumferential surface of the main body part 11.
`
`The diaphragm 20 divides the inside of the housing 10 into the blood chamber 14 and the air
`
`chamber 15.
`
`[0012]
`
`
`
`As shown in FIG. 1, the blood inflow tube part 11a provided projecting from the
`
`main body part 11 of the housing 10 has a blood inflow tube 31 connected thereto. The
`
`blood inflow tube part 11a is provided with a contraflow-preventing valve 11c that is opened
`
`only when blood flows into the blood chamber 14 of the housing 10 from the blood inflow
`
`tube 31, and prevents the blood from flowing out into the blood inflow tube 31 from the
`
`5
`
`Nipro Ex. 1021
`
`000005
`
`
`
`blood chamber 14.
`
`[0013]
`
`
`
`Further, as shown in FIG. 2, the blood outflow tube part 11b has a blood outflow
`
`tube 32 connected thereto. The blood outflow tube part 11b is provided with a contraflow-
`
`preventing valve 11d that is opened only when the blood in the blood chamber 14 of the
`
`housing 10 flows out to the blood outflow tube 32, and prevents the blood from flowing into
`
`the blood chamber 14 from the blood outflow tube 32.
`
`[0014]
`
`
`
`The back plate part 12 is formed for example of composite resin, and has a shape to
`
`which an air connector 16 can be attached. The air connector 16 to be attached to the back
`
`plate 12 has an air tube connected to an air pump and the like coupled thereto, where air is
`
`supplied to the air chamber 15 via the air connector 16, and the air is discharged from the air
`
`chamber 15. Due to this, the diaphragm 20 in the housing 10 is pumped in pulses so as to
`
`contract and inflate the blood chamber 14.
`
`[0015]
`
`
`
`A film thickness of the diaphragm 20 is configured such that its peripheral part is
`
`made thick, and becomes gradually thin towards a center part. The film thickness of the
`
`diaphragm 20 is configured for example as follows for example. As shown in FIG. 3, a
`
`radius of the diaphragm 20 is set to be R, and the diaphragm 20 is divided concentrically into
`
`three regions, namely a center part C, a peripheral part A, and a center part B between the
`
`aforementioned parts. At this occasion, the center part C is set as a region within a
`
`concentric circle of a radius R/4 relative to the diaphragm 20, the center part B is set as a
`
`region on the outer side of the center part C, and as a region within a concentric circle of a
`
`radius R/2 relative to the diaphragm 20, and further the peripheral part A is set to be a region
`
`on the outer side of the center part B. The diaphragm 20 is configured, with respect to such
`three regions, that a film thickness TA of the peripheral part A is in a range of 0.2 to 2.0 mm, a
`film thickness TB of the intermediate part B is 70 to 95% of the film thickness TA of the
`peripheral part A, and further, a film thickness TC of the center part C is 50 to 90% of the film
`thickness TA of the peripheral part A, as a result of which a smooth film thickness gradient is
`6
`
`Nipro Ex. 1021
`
`000006
`
`
`
`formed from the outer circumferential edge toward the center as a whole.
`
`[0016]
`
`
`
`An inner circumferential surface of the main body part 11 of the housing 10 and the
`
`diaphragm 20 in the blood pump as configured above are formed by using injection molding
`
`method, slash molding method, centrifugal casting method and the like using an anti-
`
`coagulant polymer material. A case of manufacturing the blood pump of the present
`
`invention by forming the diaphragm 20 and the inner circumferential surface of the main
`
`body part 11 of the housing 10 by the centrifugal casting method using the anti-coagulant
`
`polymer material will be described below.
`
`[0017]
`
`
`
`Firstly, a diaphragm having a predetermined film thickness gradient is formed by the
`
`centrifugal casting method. In this formation, 10% to 20% solution of polyether urethane
`
`urea (for example, TM series, manufactured by Toyo Boseki Co., Ltd.) being the anti-
`
`coagulant polymer material is filled in a diaphragm mold by 2 to 15g, or preferably by 7 to
`
`10g, a centrifugal force is applied by rotation while heating the mold so that the solution is
`
`adhered to an entire region of an inner circumferential surface of the mold. After this
`
`solution is sufficiently dried, a solution that has 2 to 5% less concentration than the
`
`aforementioned solution is filled on the inner circumferential surface of the mold by 5 to 20g,
`
`or preferably 10 to 20g. Then, the centrifugal force is applied by rotation while heating the
`
`mold so that the solution is adhered to the entire region of the inner circumferential surface of
`
`the mold. The solution is then dried. As above, the diaphragm 20 having the
`
`predetermined film thickness gradient is formed by changing the solution concentration and
`
`the rotation speed of the mold upon applying the centrifugal force.
`
`[0018]
`
`
`
`Accordingly, the diaphragm 20 having the predetermined film thickness gradient is
`
`obtained. In order to integrally attach the diaphragm to the inner circumferential surface of
`
`the main body part 11 of the housing 10, the mold including the diaphragm is placed to cover
`
`the main body part 11 of the housing 10 formed in a predetermined shape by a composite
`
`resin or anti-coagulant polymer material, 3 to 10% solution of an anti-coagulant polymer
`
`7
`
`Nipro Ex. 1021
`
`000007
`
`
`
`material (for example, TM series, manufactured by Toyo Boseki Co., Ltd.) of a similar type
`
`as the diaphragm 20 is poured onto the inner circumferential surface of the main body part 11,
`
`unnecessary solution is removed after 1 to 20 minutes of degassing, and the adhered solution
`
`is then dried. With such a process being repeated 3 to 8 times, or preferably 4 to 6 times, the
`
`main body part 11 of the housing 10, of which inner circumferential surface is covered by the
`
`anti-coagulant polymer material, and including the diaphragm 20 integrated with the inner
`
`circumferential surface and being formed of the anti-coagulant polymer material with the
`
`predetermined film gradient, is obtained. Further, the blood pump of the present invention
`
`is obtained by joining the main body part 11 airtight with the back plate part 12 formed in a
`
`predetermined shape by composite resin.
`
`[0019]
`
`
`
`In the blood pump of the present invention, as the anti-coagulant polymer materials
`
`to configure the diaphragm 20 and the inner circumferential surface of the main body part 11
`
`of the housing 10, a material having anti-coagulant performance may suitably be used, such
`
`as polyether urethane urea, polyether urethane, polyester urethane urea, polyester urethane,
`
`polyether urethane urea-polydimethylsiloxane copolymer, polyether urethane-
`
`polydimethylsiloxane copolymer, or polyester urethane –polydimethylsiloxane copolymer.
`
`Further, any anti-coagulant polymer material that may heretofore be developed may be used.
`
`The blood pump of the present invention is not limited to the one depicted in FIGS. 1 and 2.
`
`(Working Effects)
`
`[0020]
`
`
`
`A pulsation movement of the diaphragm 20 in the blood pump of the present
`
`invention is shown in FIG. 4. The diaphragm 20 has the thick peripheral part A and the thin
`
`center part C, so the stress on the center part C is small; and under a normal pressure, as
`
`shown in FIG. 4 (i), the diaphragm 20 is sucked into the air chamber 15 and the blood
`
`chamber 14 is in a state of somewhat being inflated. From such a state, when the air is
`
`supplied to the air chamber 15 and positive pressure is applied to the diaphragm 20, the
`
`diaphragm 20 is pressed into the blood chamber 14 from the center part C with the small
`
`stress and the blood chamber 14 contracts as shown in FIG. 4 (ii), and then the intermediate
`
`8
`
`Nipro Ex. 1021
`
`000008
`
`
`
`part B is pressed into the blood chamber 14 as shown in FIG. 4 (ii) and the blood chamber 14
`
`further contracts, and finally, as shown in Fig. 4 (iii), the peripheral part A is pressed into the
`
`blood chamber 14 and the blood chamber 14 comes to be in the maximum contracted state.
`
`[0021]
`
`
`
`On the other hand, when the blood chamber 14 is in the maximum contracted state as
`
`shown in Fig. 4 (iii) and the negative pressure is applied to the diaphragm 20 by discharging
`
`the air from the air chamber 15, as shown in FIG. 4 (ii), the intermediate part B is sucked into
`
`the air chamber 15 starting from the peripheral part A, and then, as shown in FIG. 4 (i), the
`
`center part C with the small stress of the diaphragm 20 is sucked into the air chamber 15, and
`
`the blood chamber 14 comes to be in the maximum inflated state.
`
`[0022]
`
`
`
`As is apparent from the fact that the blood chamber 14 exhibits such contraction and
`
`inflation movement by the diaphragm 20, only a small negative pressure is required to suck
`
`the center part C of the diaphragm 20 being a thin film upon inflating the diaphragm 20, thus
`
`the introduction of blood into the blood chamber 14 becomes easier, and in addition, the risk
`
`of hemolysis is reduced since the blood is introduced into the blood chamber 14 at moderate
`
`pace. Furthermore, the diaphragm 20 has the film thickness gradient in which it becomes
`
`thinner toward the center part, the pulsation movement of the diaphragm 20 is made constant
`
`at all times, and the blood flow state becomes stable in the blood chamber 14. As a result,
`
`the anti-coagulant performance would not decrease and the local stress being accumulated in
`
`the diaphragm 20 would not occur, so the durability can significantly be improved.
`
`[0023]
`
`
`
`Next, specific experiment example and comparative example using the blood pump
`
`of the present invention will be described.
`
`[0024]
`
`Example 1
`
`
`
`With the blood pump of the present invention obtained as described above, a
`
`performance test was carried out using a water simulated circuit. The film thickness of the
`
`diaphragm in the blood pump was measured, and the results shown in Table 1 were obtained.
`
`9
`
`Nipro Ex. 1021
`
`000009
`
`
`
`As a result of the performance test with the water simulated circuit, a driving condition for
`
`obtaining a pumping amount of 6.0 l/min by a pulsation number of 100 times/min was
`
`driving positive pressure of 150 mmHg, driving negative pressure of -40 mmHg, and
`
`contraction rate of 38%.
`
`[0025]
`
`
`
`A blood pump having a diaphragm with similar film thickness gradient as the
`
`diaphragm in this blood pump was attached to a mature goat, the device was driven for 1
`
`month under the above driving condition, and blood clots or hemolysis was not recognized in
`
`the blood, and the blood pump was driven in safely in good condition.
`
`[0026]
`
`Example 2
`
`
`
`A performance test was carried out with the blood pump of the present invention,
`
`using a water simulated circuit similar to the Example 1. The film thickness of the
`
`diaphragm in the blood pump was measured, and the results were as shown in Table 1. As a
`
`result of the performance test, the driving condition for obtaining the pumping amount of 6.0
`
`l/min by the pulsation number of 100 times/min was driving positive pressure of 220 mmHg,
`
`driving negative pressure of -50 mmHg, and contraction rate of 36%. A blood pump having
`
`a diaphragm with similar film thickness gradient as the diaphragm in this blood pump was
`
`attached to a mature goat, the device was driven for 1 month under the above driving
`
`condition, and blood clots or hemolysis was not recognized in the blood, and the blood pump
`
`was driven in safely in good condition.
`
`[0027]
`
`Example 3
`
`
`
`A performance test was carried out with the blood pump of the present invention,
`
`using a water simulated circuit similar to the Example 1. The film thickness of the
`
`diaphragm in the blood pump was measured, and the results were as shown in Table 1. As a
`
`result of the performance test, the driving condition for obtaining the pumping amount of 6.0
`
`l/min by the pulsation number of 100 times/min was driving positive pressure of 250 mmHg,
`
`driving negative pressure of -60 mmHg, and contraction rate of 35%. A blood pump having
`
`10
`
`Nipro Ex. 1021
`
`000010
`
`
`
`a diaphragm with similar film thickness gradient as the diaphragm in this blood pump was
`
`attached to a mature goat, the device was driven for 1 month under the above driving
`
`condition, and blood clots or hemolysis was not recognized in the blood, and the blood pump
`
`was driven in safely in good condition.
`
`[0028]
`
`Comparative Example 1
`
`
`
`As shown in Table 1, a performance test was carried out with a blood pump provided
`
`with a diaphragm having a substantially uniform film thickness, using a water simulated
`
`circuit similar to the Example 1. As a result of the performance test, the driving condition
`
`for obtaining the pumping amount of 6.0 l/min by the pulsation number of 100 times/min was
`
`driving positive pressure of 220 mmHg, driving negative pressure of -100 mmHg, and
`
`contraction rate of 45%. A blood pump having a diaphragm with similar film thickness as
`
`the diaphragm in this blood pump was attached to a mature goat, the device was driven under
`
`the above driving condition, hemolysis was recognized in the blood on the second day from
`
`when the device started to be driven, and the hemolysis worsened on the third day which
`
`required blood transfusion. However, the hemolysis tendency did not improve, so the
`
`experiment was discontinued.
`
`[0029]
`
`Comparative Example 2
`
`
`
`As shown in Table 1, a performance test was carried out with a blood pump provided
`
`with a diaphragm having a substantially uniform film thickness, using a water simulated
`
`circuit similar to the Example 1. As a result of the performance test, the blood pump was
`
`driven at its substantially maximum driving condition, namely the pulsation number of 100
`
`times/min, driving positive pressure of 300 mmHg, driving negative pressure of -100 mmHg,
`
`and contraction rate of 50%, however the flow rate of 6.0 l/min could not be obtained.
`
`When the pulsation number was set to 120 times/min, the flow rate of 6.0 l/min was obtained
`
`under the driving condition of driving positive pressure of 280 mmHg, driving negative
`
`pressure of -100 mmHg, and contraction rate of 42%.
`
`11
`
`Nipro Ex. 1021
`
`000011
`
`
`
`Table 1
`
`Peripheral Part (A) (mm)
`
`Center Part (B) (mm)
`
`Center Part (C) (mm)
`
`Film Thickness Ratio to A (%)
`
`Example 1
`
`Example 2
`
`Example 3
`
`Comparative Example 1
`
`Comparative Example 2
`
`(Advantageous Effects of Invention)
`
`[0030]
`
`
`
`As above, the blood pump of the present invention is configured to have the
`
`diaphragm that is thick at its peripheral part and becomes gradually thinner toward the center
`
`part, so the driving negative pressure for the diaphragm upon inflating the blood chamber and
`
`the driving positive pressure for the diaphragm upon contracting the blood chamber can be
`
`reduced, and the necessary flow rate can easily be obtained. Further, since the diaphragm is
`
`driven smoothly, the blood flow will not be deposited internally, thus the anti-coagulant
`
`performance would not decrease. In addition, with the low driving negative pressure for the
`
`diaphragm upon inflating the blood chamber, the blood can be introduced into the blood
`
`pump at the moderate pace, and there is not risk of the occurrence of hemolysis.
`
`4.
`
`Brief Description of Drawings
`
`[0031]
`
`
`
`FIG. 1 is a cross sectional diagram showing an example of a blood pump of the
`
`present invention, FIG. 2 is a cross sectional diagram for explaining an operation thereof, FIG.
`
`3 is an explanatory diagram of a film thickness gradient of a diaphragm, and FIG. 4 (i) to (iii)
`
`are cross sectional diagrams for explaining an operation of the diaphragm.
`
`12
`
`Nipro Ex. 1021
`
`000012
`
`
`
`
`
`10 … Housing, 11 … Main Body Part, 12 … Back Plate Part, 14 … Blood Chamber,
`
`15 … Air Chamber, 20 … Diaphragm
`
`Agent: Patent Attorney Shusaku YAMAMOTO
`
`End
`
`13
`
`Nipro Ex. 1021
`
`000013
`
`
`
`Figure 1
`
`Figure 3
`
`Figure 2
`
`Figure 4
`
` (a)
`
`(b)
`
`(c)
`
`14
`
`Nipro Ex. 1021
`
`000014
`
`
`
`TRANSLATOR'S DECLARATION
`
`I, Yuichi KAWASHIMA of Honyaku Center Inc. residing at Mita MT
`
`Bldg. 7F, 3-13-12 Mita, Minato—ku, Tokyo, 108-0073 Japan, am
`
`a Japanese language translator with over five years of
`
`experience translating technical,
`
`legal, and business
`
`documents from Japanese to English and from English to Japanese.
`
`Being fluent in both the Japanese and English languages,
`
`I
`
`certify under penalty of perjury under the laws of the United
`
`States that:
`
`1.
`
`To the best of my knowledge and belief,
`
`the preceding
`
`document is a true and correct English translation of Japanese.
`
`Patent Publication No. 564-29267. Paragraph numbers have been
`
`added,
`
`to aid in citation;
`
`2. All statements made herein of my own knowledge are true
`
`and that all statements made on information and belief are
`
`believed to be true; and
`
`3. Thisdeclaratidnwasmadewithknowledgethatwillfulfalse
`
`statements and the like so made are punishable by fine or
`
`imprisonment or both under 18 U.S.C. § 1001.
`
`Date:
`
`February 3, 2016
`
`Translator Name:
`
`Yuichi KAWASHIMA
`
`000015
`
`Nipro Ex. 1021
`
`Nipro Ex. 1021
`
`000015